MedTrace Logo

Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study

NCT05383235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-24

No results posted yet for this study

Summary

This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).

Conditions

  • Child Sexual Abuse
  • Emotion Recognition

Interventions

OTHER

ROUTINE CARE

1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient

DEVICE

Facial emotion stimuli prensentation task with EEG recording and facial emotion recognition task

2\. RUN-IN PERIOD : * Eligibility criteria will be assessed during the multidisciplinary meeting; * Study presentation, delivery of the information note and consent form; 3. STUDY: * Collection of consent form; * Facial emotion stimuli presentation task with EEG recording and facial emotion recording task; * Neuropsychological evaluation (TOM-15); * Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE); * Debriefing.

Sponsors & Collaborators

  • Hôpital le Vinatier

    lead OTHER

Principal Investigators

  • Sabine MOUCHET, PH · CH le Vinatier

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-12
Primary Completion
2025-05-15
Completion
2025-05-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05383235 on ClinicalTrials.gov